Retrospective cohort study reveals 73.3% organ preservation following transanal endoscopic microsurgery for rectal cancer, highlighting the need for risk-adapted staging.
Background Long-term outcomes and preoperative predictors after organ-sparing transanal endoscopic microsurgery (TEM) for rectal cancer remain incompletely defined. We assessed overall survival (OS), disease-free survival (DFS), and preoperative predictors.Methods Consecutive patients undergoing TEM with organ-sparing intent for rectal adenocarcinoma between February 1993 and April 2025 were retrospectively analysed. Preoperative variables included age, sex, lesion diameter, distance from the anal verge, location, histology, and endoscopic ultrasound (EUS) uT stage. Survival was estimated by Kaplan–Meier analysis and Cox regression.Results 333 patients were included (median age 71 years; 63.1% male), with a median follow-up of 24 months. Post-TEM management comprised surveillance (28.5%), completion radical surgery (17.1%), or (chemo)radiotherapy (44.7%). Rectal preservation was achieved in 73.3%. 88 patients died and 71 developed recurrence, including 58 local and 26 distant recurrences. On multivariable analysis, age ≥71 years (adjusted HR 2.35, 95% CI 1.38–4.00; p = 0.002) and EUS uT2–3 (adjusted HR 2.11, 95% CI 1.23–3.63; p = 0.007) independently predicted worse OS.Conclusions Organ-sparing TEM achieved rectal preservation in nearly three-quarters of patients, although recurrence was predominantly local. Age and EUS uT stage predicted OS, supporting staging and risk-adapted escalation.
No takes yet. Share an insight, caveat, or question.
Arezzo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: